Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2016-05-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Stability of Mail-in Capillary Hemoglobin A1c Test Kit
NCT00511030
A Normal Donor Sample Collection Study in Healthy Adults
NCT01318863
Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells
NCT04418934
Autonomous Blood Drawing Optimization and Performance Testing
NCT05878483
LCI Apheresis to Obtain Plasma or White Blood Cells
NCT00562601
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject has adequate understanding of the procedures of the study.
3. Subject is able to communicate well with the investigator.
4. Subject has signed informed consent.
5. Subject refrains from donation to the Sanquin blood bank.
Exclusion Criteria
2. For female participants: pregnancy or lactation.
3. Presence of any chronic systemic condition, which could compromise the health of the volunteer when performing venepuncture or interfere with the interpretation of immunological or metabolic test results.
4. Chronic use of immunosuppressive drugs.
5. Total blood volume donated exceeding \>500 mL in the past 4 months.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Leiden University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Meta Roestenberg
MD, PhD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mini Donor Bank
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.